Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GDNR Stock Summary
In the News
GDNR Financial details
Company Rating
Sell
Market Cap
40.97M
Income
-939.89K
Revenue
0
Book val./share
4.4
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-39.11
Forward P/E
-
PEG
10.35
P/S
-
P/B
1.31
P/C
272.5
P/FCF
-113.53
Quick Ratio
0.08
Current Ratio
0.17
Debt / Equity
0.06
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-670.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
94.17%
-
-
-
-
SMA20
0.46%
SMA50
-
SMA100
-
Inst Own
50.2%
Inst Trans
0.77%
ROA
-3%
ROE
-1%
ROC
-0.06%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.28-12.02
52W High
-9.17%
52W Low
+9%
RSI
57.51
Rel Volume
-
Avg Volume
1.51K
Volume
Perf Week
0%
Perf Month
0.83%
Perf Quarter
-
Perf Half Y
0.93%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0.04%
Prev Close
0%
Price
10.9
Change
0%
GDNR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.04 | 0.04 | |
Operating cash flow per share | -0.11 | -0.12 | |
Free cash flow per share | -0.11 | -0.12 | |
Cash per share | 624.19 | 0 | |
Book value per share | 32.56K | 1.75 | |
Tangible book value per share | 32.56K | 1.75 | |
Share holders equity per share | 32.56K | 1.75 | |
Interest debt per share | 110.78 | -0.38 | |
Market cap | 22.6K | 108.84M | |
Enterprise value | -1.16M | 109.42M | |
P/E ratio | -266.85 | 246.14 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -86.23 | -82.2 | |
PFCF ratio | -86.23 | -82.2 | |
P/B Ratio | 0 | 5.87 | |
PTB ratio | 0 | 5.87 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -3.47K | -27.31 | |
EV to operating cash flow | 4.42K | -82.63 | |
EV to free cash flow | 4.42K | -82.63 | |
Earnings yield | 0 | 0 | |
Free cash flow yield | -0.01 | -0.01 | |
Debt to equity | 0 | 0.03 | |
Debt to assets | 0 | 0.03 | |
Net debt to EBITDA | -3.53K | -0.14 | |
Current ratio | 5.02 | 0.19 | |
Interest coverage | 0 | 0.86 | |
Income quality | 3.09 | -2.99 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 164.19 | 1.28 | |
ROIC | 0 | -0.14 | |
Return on tangible assets | 0 | 0.02 | |
Graham Net | -361.94 | -0.19 | |
Working capital | 1.17M | -1.16M | |
Tangible asset value | 74.94M | 18.53M | |
Net current asset value | -813.96K | -1.76M | |
Invested capital | 0 | 0.03 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 289.99K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0.02 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.04 | -0.03 | 0.03 | -0.05 | -0.1 | |
Operating cash flow per share | -0.08 | -0.03 | -0.02 | 0 | -0.05 | |
Free cash flow per share | -0.08 | -0.03 | -0.02 | 0 | -0.05 | |
Cash per share | 0.05 | 0.02 | 0.01 | 0 | 0.04 | |
Book value per share | 8.04 | 8.06 | 8.09 | 1.84 | 4.4 | |
Tangible book value per share | 8.04 | 8.06 | 8.09 | 1.84 | 4.4 | |
Share holders equity per share | 8.04 | 8.06 | 8.09 | 1.84 | 4.4 | |
Interest debt per share | 0.03 | 0.03 | 0.03 | -0.01 | 0.26 | |
Market cap | 106.63M | 107.06M | 107.7M | 103.19M | 42.8M | |
Enterprise value | 106.41M | 107.09M | 107.92M | 103.77M | 43.69M | |
P/E ratio | 59.63 | -78.96 | 79.68 | -49.86 | -25.39 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -117.63 | -389.38 | -581.19 | 2.42K | -196.2 | |
PFCF ratio | -117.63 | -389.38 | -581.19 | 2.42K | -196.2 | |
P/B Ratio | 1.23 | 1.23 | 1.23 | 5.57 | 2.38 | |
PTB ratio | 1.23 | 1.23 | 1.23 | 5.57 | 2.38 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -70.99 | -122.42 | -176.8 | -101.48 | -59 | |
EV to operating cash flow | -117.4 | -389.5 | -582.36 | 2.44K | -200.27 | |
EV to free cash flow | -117.4 | -389.5 | -582.36 | 2.44K | -200.27 | |
Earnings yield | 0 | 0 | 0 | -0.01 | -0.01 | |
Free cash flow yield | -0.01 | 0 | 0 | 0 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0.03 | 0.06 | |
Debt to assets | 0 | 0 | 0 | 0.03 | 0.05 | |
Net debt to EBITDA | 0.14 | -0.04 | -0.36 | -0.57 | -1.2 | |
Current ratio | 1.63 | 1.04 | 0.64 | 0.19 | 0.17 | |
Interest coverage | 0 | 0 | 0 | 1.45 | 0 | |
Income quality | -2.03 | -1.57 | -0.55 | -0.08 | 0.52 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.74 | 2.39 | 2.39 | 1.46 | 3.19 | |
ROIC | -0.01 | 0 | 0 | -0.09 | -0.02 | |
Return on tangible assets | 0.01 | 0 | 0 | -0.03 | -0.02 | |
Graham Net | -0.09 | -0.07 | -0.07 | -0.2 | -0.6 | |
Working capital | 318.17K | 22.61K | -205.14K | -1.16M | -1.76M | |
Tangible asset value | 86.7M | 86.88M | 87.22M | 18.53M | 18M | |
Net current asset value | -602.22K | -440.11K | -477.71K | -1.76M | -2.27M | |
Invested capital | 0 | 0 | 0 | 0.03 | 0.06 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 102.54K | 159.75K | 151.8K | 349.58K | 641.38K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0 | 0 | -0.03 | -0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
GDNR Frequently Asked Questions
What is Gardiner Healthcare Acquisitions Corp. stock symbol ?
Gardiner Healthcare Acquisitions Corp. is a US stock , located in Shaker heights of Oh and trading under the symbol GDNR
What is Gardiner Healthcare Acquisitions Corp. stock quote today ?
Gardiner Healthcare Acquisitions Corp. stock price is $10.9 today.
Is Gardiner Healthcare Acquisitions Corp. stock public?
Yes, Gardiner Healthcare Acquisitions Corp. is a publicly traded company.